ARRY
Price
$8.26
Change
+$0.09 (+1.10%)
Updated
Sep 26 closing price
Capitalization
1.26B
38 days until earnings call
IBRX
Price
$2.54
Change
+$0.08 (+3.25%)
Updated
Sep 26 closing price
Capitalization
2.4B
39 days until earnings call
Interact to see
Advertisement

ARRY vs IBRX

Header iconARRY vs IBRX Comparison
Open Charts ARRY vs IBRXBanner chart's image
Array Technologies
Price$8.26
Change+$0.09 (+1.10%)
Volume$3.12M
Capitalization1.26B
ImmunityBio
Price$2.54
Change+$0.08 (+3.25%)
Volume$5.81M
Capitalization2.4B
ARRY vs IBRX Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. IBRX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a StrongBuy and IBRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ARRY: $8.26 vs. IBRX: $2.54)
Brand notoriety: ARRY and IBRX are both not notable
ARRY represents the Alternative Power Generation, while IBRX is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARRY: 40% vs. IBRX: 59%
Market capitalization -- ARRY: $1.26B vs. IBRX: $2.4B
ARRY [@Alternative Power Generation] is valued at $1.26B. IBRX’s [@Biotechnology] market capitalization is $2.4B. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $118.24B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Alternative Power Generation] industry is $1.99B. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRY’s FA Score shows that 1 FA rating(s) are green whileIBRX’s FA Score has 1 green FA rating(s).

  • ARRY’s FA Score: 1 green, 4 red.
  • IBRX’s FA Score: 1 green, 4 red.
According to our system of comparison, ARRY is a better buy in the long-term than IBRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while IBRX’s TA Score has 5 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 3 bearish.
  • IBRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ARRY is a better buy in the short-term than IBRX.

Price Growth

ARRY (@Alternative Power Generation) experienced а +2.35% price change this week, while IBRX (@Biotechnology) price change was -6.96% for the same time period.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was -1.69%. For the same industry, the average monthly price growth was +7.12%, and the average quarterly price growth was +38.72%.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.96%. For the same industry, the average monthly price growth was +9.24%, and the average quarterly price growth was +51.43%.

Reported Earning Dates

ARRY is expected to report earnings on Nov 06, 2025.

IBRX is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Alternative Power Generation (-1.69% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

@Biotechnology (+3.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($2.4B) has a higher market cap than ARRY($1.26B). ARRY YTD gains are higher at: 36.755 vs. IBRX (-0.781). ARRY has higher annual earnings (EBITDA): -127.81M vs. IBRX (-237.93M). ARRY has more cash in the bank: 377M vs. IBRX (154M). IBRX has less debt than ARRY: IBRX (535M) vs ARRY (694M). ARRY has higher revenues than IBRX: ARRY (1.17B) vs IBRX (56.6M).
ARRYIBRXARRY / IBRX
Capitalization1.26B2.4B53%
EBITDA-127.81M-237.93M54%
Gain YTD36.755-0.781-4,705%
P/E Ratio56.91N/A-
Revenue1.17B56.6M2,069%
Total Cash377M154M245%
Total Debt694M535M130%
FUNDAMENTALS RATINGS
ARRY vs IBRX: Fundamental Ratings
ARRY
IBRX
OUTLOOK RATING
1..100
1887
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4362
P/E GROWTH RATING
1..100
26100
SEASONALITY SCORE
1..100
1450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IBRX's Valuation (4) in the Biotechnology industry is significantly better than the same rating for ARRY (93). This means that IBRX’s stock grew significantly faster than ARRY’s over the last 12 months.

IBRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that IBRX’s stock grew similarly to ARRY’s over the last 12 months.

IBRX's SMR Rating (100) in the Biotechnology industry is in the same range as ARRY (100). This means that IBRX’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's Price Growth Rating (43) in the Biotechnology industry is in the same range as IBRX (62). This means that ARRY’s stock grew similarly to IBRX’s over the last 12 months.

ARRY's P/E Growth Rating (26) in the Biotechnology industry is significantly better than the same rating for IBRX (100). This means that ARRY’s stock grew significantly faster than IBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYIBRX
RSI
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 14 days ago
85%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCVIX33.220.40
+1.22%
MFS Mid Cap Value I
TOLLX16.770.15
+0.90%
DWS RREEF Global Infrastructure A
STMDX35.710.30
+0.85%
Sterling Capital Real Estate I
RIVAX19.870.13
+0.66%
American Funds International Vntg R-1
WINDX37.140.23
+0.62%
FT Wilshire 5000 Index Instl